Global Health Justice

Big Pharmaceuticals


January 26, 2025

Reducing Import Reliance: Morocco Paves the Way for Africa’s Autonomy

By Alina Metje, GHJ Team

The Moroccan company Moldiag’s production of Africa’s first mpox tests stands as a refreshing contrast to the traditional narrative of reliance on high-income nations for medical supplies. Amid a history of global inequities exposed during the COVID-19 pandemic, this effort underscores the importance of South-South partnerships and self-reliance in addressing public health challenges. Moldiag, founded…


August 20, 2024

Mpox: A Looming Threat to Global Health Security, A Renewed Call for Solidarity

By Patience Komba, GHJ Team

Mpox: A Public Health Emergency of International Concern As the world continues to grapple with the consequences of the COVID-19 pandemic, a new public health threat is emerging: Mpox. The World Health Organization (WHO) and the Africa CDC have declared Mpox a public health emergency of international concern, urging the global community to take immediate…


June 21, 2024

Profit Over Patients: Insulin Pen Shortage in South Africa

By Alina Metje, GHJ Team

South Africa is running out of insulin pens due to Novo Nordisk’s decision not to renew its contract, focusing instead on more profitable weight- loss drugs. The shift to vials represents a step backward in diabetes care. Vials and syringes are harder to use and less precise, raising concerns about medication adherence and long-term complications….